Fifth Third Bancorp Lowers Holdings in Zoetis Inc. $ZTS

Fifth Third Bancorp cut its stake in Zoetis Inc. (NYSE:ZTS) by 5.1% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 162,140 shares of the company’s stock after selling 8,637 shares during the period. Fifth Third Bancorp’s holdings in Zoetis were worth $23,724,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Phillips Wealth Planners LLC grew its stake in shares of Zoetis by 6.1% during the 3rd quarter. Phillips Wealth Planners LLC now owns 2,013 shares of the company’s stock valued at $293,000 after buying an additional 115 shares during the period. Amica Mutual Insurance Co. increased its stake in Zoetis by 33.7% during the third quarter. Amica Mutual Insurance Co. now owns 28,906 shares of the company’s stock worth $4,229,000 after acquiring an additional 7,293 shares during the last quarter. Pallas Capital Advisors LLC lifted its stake in shares of Zoetis by 24.8% in the 3rd quarter. Pallas Capital Advisors LLC now owns 15,585 shares of the company’s stock valued at $2,280,000 after purchasing an additional 3,097 shares in the last quarter. State of New Jersey Common Pension Fund D grew its holdings in shares of Zoetis by 2.6% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 156,062 shares of the company’s stock worth $22,835,000 after purchasing an additional 3,897 shares during the period. Finally, Uhlmann Price Securities LLC increased its position in Zoetis by 44.6% during the 3rd quarter. Uhlmann Price Securities LLC now owns 3,300 shares of the company’s stock worth $483,000 after purchasing an additional 1,018 shares in the last quarter. Institutional investors and hedge funds own 92.80% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on ZTS. Stifel Nicolaus reduced their target price on shares of Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday, November 18th. Wall Street Zen raised Zoetis from a “hold” rating to a “buy” rating in a report on Friday, January 23rd. Weiss Ratings downgraded Zoetis from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, January 28th. JPMorgan Chase & Co. dropped their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research report on Wednesday, November 5th. Finally, Piper Sandler reiterated a “neutral” rating and set a $135.00 target price (down previously from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, Zoetis has an average rating of “Hold” and an average target price of $152.91.

Zoetis Stock Up 0.8%

ZTS opened at $126.64 on Tuesday. Zoetis Inc. has a one year low of $115.25 and a one year high of $177.00. The company has a debt-to-equity ratio of 2.71, a quick ratio of 1.94 and a current ratio of 3.03. The company has a market capitalization of $53.46 billion, a PE ratio of 21.04, a P/E/G ratio of 2.12 and a beta of 0.96. The stock’s fifty day moving average is $124.59 and its 200-day moving average is $135.21.

Zoetis (NYSE:ZTS) last announced its quarterly earnings data on Thursday, February 12th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.08. The company had revenue of $2.39 billion during the quarter, compared to the consensus estimate of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.The company’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. On average, equities analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 2nd. Stockholders of record on Monday, April 20th will be issued a dividend of $0.53 per share. The ex-dividend date of this dividend is Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 1.7%. Zoetis’s dividend payout ratio is currently 35.22%.

About Zoetis

Zoetis Inc (NYSE: ZTS) is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company’s offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.